600056 Stock Overview
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
China Meheco Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.01 |
| 52 Week High | CN¥15.50 |
| 52 Week Low | CN¥9.78 |
| Beta | 0.14 |
| 1 Month Change | -0.81% |
| 3 Month Change | 9.88% |
| 1 Year Change | -22.57% |
| 3 Year Change | 16.95% |
| 5 Year Change | 4.43% |
| Change since IPO | 507.65% |
Recent News & Updates
Shareholder Returns
| 600056 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 1.9% | 0.8% | -0.4% |
| 1Y | -22.6% | -32.5% | -16.2% |
Return vs Industry: 600056 exceeded the CN Healthcare industry which returned -32.5% over the past year.
Return vs Market: 600056 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
| 600056 volatility | |
|---|---|
| 600056 Average Weekly Movement | 5.1% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 600056 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600056's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 8,313 | Huidong Hu | www.meheco.com |
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products.
China Meheco Group Co., Ltd. Fundamentals Summary
| 600056 fundamental statistics | |
|---|---|
| Market cap | CN¥16.47b |
| Earnings (TTM) | CN¥563.10m |
| Revenue (TTM) | CN¥40.47b |
29.2x
P/E Ratio0.4x
P/S RatioIs 600056 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600056 income statement (TTM) | |
|---|---|
| Revenue | CN¥40.47b |
| Cost of Revenue | CN¥35.98b |
| Gross Profit | CN¥4.50b |
| Other Expenses | CN¥3.93b |
| Earnings | CN¥563.10m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 11.11% |
| Net Profit Margin | 1.39% |
| Debt/Equity Ratio | 37.6% |
How did 600056 perform over the long term?
See historical performance and comparison